| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Y-mAbs Therapeutics, Inc. | Director | Common Stock | 0 | $0 | $8.52 | 16 Sep 2025 | Direct |
| Y-mAbs Therapeutics, Inc. | Director | Employee Stock Option (right to buy) | 0 | 16 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| YMAB | Y-mAbs Therapeutics, Inc. | 16 Sep 2025 | 10 | -$50,095 | 4 | Director | 18 Sep 2025, 21:24 |
| YMAB | Y-mAbs Therapeutics, Inc. | 30 Jun 2025 | 2 | $0 | 4 | Director | 02 Jul 2025, 16:20 |
| YMAB | Y-mAbs Therapeutics, Inc. | 11 Jun 2024 | 2 | $0 | 4 | Director | 13 Jun 2024, 21:00 |
| YMAB | Y-mAbs Therapeutics, Inc. | 08 Jun 2023 | 2 | $0 | 4 | Director | 09 Jun 2023, 18:00 |
| YMAB | Y-mAbs Therapeutics, Inc. | 15 Jul 2022 | 1 | $0 | 4 | Director | 19 Jul 2022, 13:18 |
| YMAB | Y-mAbs Therapeutics, Inc. | 10 Jun 2021 | 1 | $0 | 4 | Director | 14 Jun 2021, 17:02 |